{{Rsnum
|rsid=312691
|Chromosome=17
|position=68326338
|Orientation=plus
|GMAF=0.3205
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 42.5 | 52.2
| HCB | 15.3 | 54.7 | 29.9
| JPT | 26.5 | 42.5 | 31.0
| YRI | 8.8 | 35.4 | 55.8
| ASW | 0.0 | 38.6 | 61.4
| CHB | 15.3 | 54.7 | 29.9
| CHD | 20.2 | 48.6 | 31.2
| GIH | 2.0 | 30.7 | 67.3
| LWK | 11.8 | 29.1 | 59.1
| MEX | 15.5 | 46.6 | 37.9
| MKK | 4.5 | 34.6 | 60.9
| TSI | 8.8 | 44.1 | 47.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22863731
  |Trait=Thyrotoxic hypokalemic periodic paralysis
  |Title=Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3.
  |RiskAllele=C
  |Pval=8E-14
  |OR=3.20
  |ORtxt=[2.40-4.40]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}